Immune Medicines
Roche’s Genentech builds autoimmune Repertoire with deal worth up to $765M
Repertoire, genentech, Autoimmune Diseases, Immune Medicines, Partnership
Actionable Insights Powered by AI
Repertoire, genentech, Autoimmune Diseases, Immune Medicines, Partnership